Shinichiro Muraoka

Stock Analyst at Morgan Stanley

(1.63)
# 3,498
Out of 5,078 analysts
36
Total ratings
53.3%
Success rate
0.1%
Average return

Stocks Rated by Shinichiro Muraoka

SanBio Company Limited
Oct 19, 2026
Reiterated: Hold
Price Target: ¥2,100 → ¥1,100
Current: ¥924
Upside: +19.05%
Takeda Pharmaceutical Company Limited
Sep 4, 2026
Reiterated: Buy
Price Target: ¥6,300 → ¥7,000
Current: ¥6,389
Upside: +9.56%
Sawai Group Holdings Co., Ltd.
Aug 12, 2026
Downgraded: Hold
Price Target: ¥2,000 → ¥1,800
Current: ¥1,718
Upside: +4.80%
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Reiterated: Buy
Price Target: ¥13,200 → ¥14,100
Current: ¥12,455
Upside: +13.21%
Kyowa Kirin Co., Ltd.
Mar 6, 2026
Downgraded: Sell
Price Target: ¥1,700
Current: ¥2,413
Upside: -29.53%
Daiichi Sankyo Company, Limited
Nov 21, 2025
Reiterated: Buy
Price Target: ¥4,750 → ¥4,950
Current: ¥2,818
Upside: +75.69%
Sumitomo Pharma Co., Ltd.
Aug 22, 2025
Upgraded: Hold
Price Target: ¥1,350
Current: ¥1,854
Upside: n/a
Astellas Pharma Inc.
May 30, 2025
Reiterated: Hold
Price Target: ¥1,750 → ¥1,500
Current: ¥2,512
Upside: n/a
Shionogi & Co., Ltd.
May 30, 2025
Reiterated: Hold
Price Target: ¥2,750
Current: ¥3,036
Upside: n/a
Eisai Co., Ltd.
May 29, 2025
Reiterated: Hold
Price Target: ¥4,100
Current: ¥5,076
Upside: n/a
Reiterated: Hold
Price Target: ¥3,900 → ¥3,800
Current: ¥3,432
Upside: n/a
Reiterated: Buy
Price Target: ¥7,650 → ¥8,050
Current: ¥6,795
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $20.24
Upside: n/a